The Hematologist

11

The Hematologist is the member newsletter of American Society of Hematology (ASH). It is designed for the broad constituency of ASH, all working toward the ultimate goal of conquering blood diseases. The Hematologist updates readers about important developments in the field of hematology and highlights what ASH is doing for its members.

Recent Episodes
  • No Scientific Link Found Between Sickle Cell Trait and Sudden Death
    Apr 28, 2025 – 21:07
  • Does This Star ‘GLO’? Taking Aim at Second-Line Diffuse Large B-Cell Lymphoma With Glofitamab Plus Gemcitabine and Oxaliplatin
    Mar 31, 2025 – 20:16
  • The Rise of the HLA-Mismatched Unrelated Donor Transplant in the U.S.
    Feb 27, 2025 – 26:16
  • The End of Transplant for Mantle Cell Lymphoma
    Jan 31, 2025 – 23:29
  • DREAMMing of a Better Tomorrow: Belantamab-Based Triplet Therapy for Relapsed/Refractory Multiple Myeloma
    Dec 21, 2024 – 18:56
  • Haploidentical Stem Cell Transplantation Is an Acceptable Transformative Therapy for Young Adults With Sickle Cell Disease
    Nov 27, 2024 – 23:43
  • Enhancing Risk Stratification for Pediatric B-Cell Acute Lymphoblastic Leukemia: No Longer a ‘PI’ in the Sky Idea?
    Oct 11, 2024 – 18:11
  • A Leap of Faith? Elimination of Autologous Stem Cell Transplantation for Patients With Mantle Cell Lymphoma in First Remission
    Sep 16, 2024 – 21:39
  • Anticoagulation Stewardship
    Aug 29, 2024 – 25:56
  • Blood Global Hematology Editor-in-Chief Shares Vision
    Jul 17, 2024 – 16:52
  • One on One With Dr. Fred Appelbaum
    Jun 26, 2024 – 26:25
  • Genetic Switch System Suggests Targeting of Mutant JAK2 Reverses Myeloproliferative Neoplasms
    Jun 21, 2024 – 23:49
  • Venous Thromboembolism Risk Markers and Discontinuing Combined Hormonal Contraceptives
    May 7, 2024 – 25:41
  • Growing the Next Generation of Hematologists
    Apr 15, 2024 – 20:14
  • Women in Hematology
    Mar 26, 2024 – 26:39
  • Four Is Better Than Three: Will We Finally Agree?
    Mar 18, 2024 – 23:18
  • Toward Equity in Access for ALL
    Jan 30, 2024 – 26:42
  • The Brilliant Success of Blinatumomab for Babies With Acute Lymphoblastic Leukemia
    Nov 29, 2023 – 16:13
  • Editors-in-Chief of Two New ASH Journals Share Their Visions
    Oct 20, 2023 – 25:16
  • ASH’s Minority Recruitment Initiative Mentorship Program Offers a Win for All
    Sep 18, 2023 – 14:20
  • Results From the Blood and Marrow Transplant Trials Network: How Should We Prevent Graft-versus-host Disease in 2023?
    Sep 1, 2023 – 28:05
  • Genetic Background Influences the Growth of CHIP Clones Within the Bone Marrow, With Drs. Robert Hasserjian and Siddhartha Jaiswal
    Jul 7, 2023 – 27:12
  • Drawing New Blood Into Hematology
    Jun 16, 2023 – 31:39
  • Anticoagulation and Abnormal Uterine Bleeding: Acknowledging Calls to Action
    May 18, 2023 – 25:13
  • ASH | FDA Collaboration: A Workshop on Regulatory Science in Hematology
    Apr 21, 2023 – 15:40
  • The Next Wave of T-cell Engagement for the Management of Diffuse Large B-cell Lymphoma, with Drs. Michael Dickinson and Loretta J. Nastoupil
    Apr 4, 2023 – 34:05
  • VTE Guidelines for Latin America Special Populations and Diagnosis (Portuguese Audio)
    Mar 22, 2023 – 25:53
  • VTE Guidelines for Latin America Special Populations and Diagnosis (Spanish Audio)
    Mar 22, 2023 – 24:39
  • VTE Guidelines for Latin America Special Populations and Diagnosis (English Audio)
    Mar 22, 2023 – 23:52
  • ASH Summit on Immunotherapies for Hematologic Diseases, With Dr. Terry Fry and Dr. Shaji Kumar
    Feb 16, 2023 – 15:07
  • GPRC5D: The Next Frontier for Immunotherapy in Multiple Myeloma, With Drs. Shaji Kumar and Saad Usmani
    Jan 20, 2023 – 19:17
  • Should Minimal Residual Disease Guide the Way? With Drs. Partow Kebriaei and Lori Muffly
    Jan 10, 2023 – 19:16
  • ASH Celebrates Hispanic Heritage Month, With Drs. Ruben Mesa, Diego Adrianzen-Herrera, & Joanna Robles, Introduced by Dr. Belinda Avalos
    Sep 22, 2022 – 29:31
  • ASH Celebra el Mes de la Herencia Hispana, Con el Dr. Ruben Mesa, el Dr. Diego Adrianzen-Herrera, & la Dra. Joanna Robles
    Sep 22, 2022 – 17:25
  • Iron-restricted Erythropoiesis in Sickle Cell Disease, With Drs. David Rees, Naja Nyffenegger, & Vania Manolova
    Sep 21, 2022 – 12:56
  • ASH and Maternal Health, With Drs. Jennifer Holter-Chakrabarty & Sarah O’Brien
    Sep 19, 2022 – 23:05
  • Trust Your Gut: Changes in Intestinal Microbiome Are Associated With Outcomes Following CAR-T Therapy, With Drs. Loretta Nastoupil & Melody Smith
    Jul 1, 2022 – 13:46
  • The Latest Sickle Cell Disease Policy Updates, With Drs. Jennifer Holter Chakrabarty & Chancellor Donald
    Jun 1, 2022 – 20:23
  • Structural Racism and Understanding Disparities in AML Outcomes, With Drs. Christine McMahon & Ivy Abraham
    May 3, 2022 – 15:04
  • A Conversation About Women in Medicine, With Drs. Shikha Jain and Laura Michaelis
    Apr 13, 2022 – 16:59
  • ASH VTE-LA Guidelines: Prevention of VTE in Latin America, With Drs. Patricia Casais & Luis Meillon-Garcia
    Mar 17, 2022 – 19:09
  • Modelling Myelofibrosis in Vivo: Success With NSG-S, With Drs. Beth Psaila and Hamza Celik
    Mar 4, 2022 – 14:34
  • Guías TEV-LA: Prevención de TEV en América Latina, Con Dras. Cecilia Colorio y Cecilia Guillermo
    Feb 25, 2022 – 19:11
  • Diretrizes TEV-LA: Prevenção de TEV na América Latina, Com Dr. Suely Rezende e Daniel Ribeiro
    Feb 25, 2022 – 24:10
  • An Interview With Pediatric Physician Scientist, Advocate, and Mentor Dr. Rayne Rouce
    Feb 9, 2022 – 21:30
  • From Myth to Reality: Achieving Second Remission in ALL, With Drs. Kristen O'Dwyer & Laura Michaelis
    Jan 13, 2022 – 12:29
  • 2021 ASH Annual Meeting: Plenary Abstract on ZUMA-7 Study, With Drs. Frederick Locke & Brad Kahl
    Dec 9, 2021 – 13:11
  • 2021 ASH Annual Meeting: COVID-19 Content at the Meeting, With Drs. Cindy Dunbar and Laura Michaelis
    Dec 7, 2021 – 14:17
  • 2021 ASH Annual Meeting: Plenary Abstract on ATLAS-INH in Patients With Hemophilia A or B With Inhibitors, Drs. Guy Young & Laura Michaelis
    Dec 2, 2021 – 13:17
  • Weighing the Risks and Benefits of DOACs in Morbidly Obese Patients, With Drs. Damon Houghton & Karlyn Martin
    Nov 1, 2021 – 18:51
Recent Reviews
Disclaimer: The podcast and artwork on this page are property of the podcast owner, and not endorsed by UP.audio.